General microbial and viral enzymes

General microbial and viral enzymes is a broad classification used to describe a diverse group of catalytic proteins essential for the survival and replication of infectious agents such as bacteria, viruses, and fungi (NCBI, 2023). This category is not a single therapeutic target but rather a grouping of various enzymes, including proteases, polymerases, and transpeptidases, which are critical for processes like cell wall synthesis and genome replication (StatPearls, 2023). Drugs targeting these enzymes, such as antibiotics and antivirals, aim to achieve selective toxicity by exploiting structural differences between the pathogen's enzymes and their human counterparts (PubMed, 2022). For example, beta-lactam antibiotics target bacterial penicillin-binding proteins, while protease inhibitors disrupt the maturation of viral particles (NIH, 2023). Because this term encompasses a vast range of distinct molecular entities, it is considered a high-level functional group rather than a specific pharmacological target (WHO, 2024). Therapeutic intervention in this area is fundamental to treating infectious diseases, though it faces significant challenges such as the rapid evolution of antimicrobial resistance (Nature, 2021). Understanding the specific structure and function of individual enzymes within this group is necessary for the development of narrow-spectrum or highly potent broad-spectrum therapies (ScienceDirect, 2023).

Other names

Microbial enzymesViral enzymesPathogen enzymesInfectious agent enzymes

Inhibition of essential microbial or viral enzymatic processes such as nucleic acid synthesis, protein cleavage, or cell wall assembly.